1 / 16

CALITC

CALITC.org. The California Israel Technology Collaborative. CALITC Mission. The California Israel Technology Collaborative is dedicated to collaboratively promoting Israeli High Technology in California and in the US

necia
Download Presentation

CALITC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CALITC.org The California Israel Technology Collaborative

  2. CALITC Mission • The California Israel Technology Collaborative is dedicated to collaboratively promoting Israeli High Technology in California and in the US • The Collaborative brings together students, alumni, faculty, staff of major Israeli Universities as well as Israeli Incubators and startup companies together with members of the Southern California academic, business, information services, life science, healthcare and other high tech communities

  3. CALITC Accomplishments • SCICC Board Membership • Larta Israel Mentoring Program • Cedars Sinai Stem Cell Conference • Lecture Events • Site Visits in Israel

  4. Three Phase Growth Plan • Phase One - infrastructure implementation • Phase Two - growth • Phase Three - stability

  5. Phase One • Obtain non-profit status • Initiate web presence • Establish Board of Advisors • Develop Business Plan • Identify first sponsors

  6. Phase Two • Develop website • Expand contacts in California • Expand contacts in Israel • Initiate local lecture series • Establish online conferences to Israeli startups • Publish newsletter • Start mentor program • Find more sponsors

  7. Phase Three • Hire full time director • Establish Scientific Advisory Board • Grow paid membership • Begin investment programs

  8. Phase One - Non Profit Status • Find temporary partner • Initiate 501(c)3 paperwork

  9. Phase One - Web Presence • California vendor database – life science companies, lawyers, accountants, VC, angel investors, banks • Israel startup database – Matimop, Israel Export Institute, Israel Life Science Industry (ILSI), Israel Venture Association (IVA), Israel incubator portfolio companies, Israeli university tech transfer offices • Member database – newsletter, lecture series • Knowledge Base – online WIKI • Community calendar

  10. Phase Two – Web Presence • Mentoring application – volunteer crowd sourcing functions, physician-startup matching program • Business enabling functions – business matching program • Expansion of WIKI Knowledge Base

  11. Phase Three – Investment Programs • Trade missions to Israel • Site visits to Israeli startups • Israel Investment Clearing House • Investment fund

  12. CALITC Founders • Bruce Kobritz, M.S. • Eddy Jakobovits, Ph.D. • Advisory Board – Shai Aizin, MBA, Philip Rosenthal, M.D.

  13. Bio – Bruce Kobritz • Bruce Kobritz is the Managing Director of Strategic Associates, a boutique Private Equity and Venture Capital investment banking firm in Brentwood, California. Strategic Associates specializes in capital formation, debt and equity capital raising, and providing financial advisory services to biotechnology, life sciences, healthcare and medical device companies. Previously, Mr. Kobritz has served as a Director of several Regional Investment Banking firms providing expertise in a range of areas including: due diligence, valuation, mergers & acquisitions, corporate restructuring, debt & equity recapitalization, and strategy consulting. Client services include: institutional placements; business plan development and presentations; debtor and creditor bankruptcy committee financial advisory services; and reorganizations. Mr. Kobritz has been a featured speaker presented at numerous Healthcare, E-Health, and Investment Banking conferences, from the Neuro Venture Forum in San Francisco to a variety of national conferences in Chicago, New Orleans, Palm Springs and Washington, D.C. He has served on the Board of Advisors for the National Managed Health Care Congress and other organizations. His numerous publications include a chapter on Medicare Managed Care for Thompson Financial Publications. A graduate of UCLA's Anderson School, he has served as a judge with the Knapp Venture Forum at UCLA, a participant in the Venture Roundtable and is a founder of the UCLAVC.ORG the School’s Venture Capital Alumni organization. Mr. Kobritz served as the Chair of the UCLA E-health Seminar Committee in 2000 and 2001, which planned the conference for The Healthcare Collaborative at UCLA's School of Public Health.

  14. Bio – Eddy Jakobovits • Dr. Edward Jakobovits is founder and President of SciWeb, Inc., (http://www.sciweb.com), an Internet-based information service for life science professionals. This collection of four web sites provides industry-specific data and job related services for the biotechnology industry. Before starting SciWeb, Dr. Jakobovits worked in the Research Department at Syva Co., the diagnostic wing of Syntex Corp. and then Behring/Dade Diagnostics. There he led the efforts to create an improved line of diagnostic reagents using molecular biology tools to synthesize mutated forms of bacterial reagents critical to the main product lines of the company. These efforts led to the creation of several multi-million dollar products in the drugs of abuse and therapeutic drug marker markets. Previously, Dr. Jakobovits worked as the head of the Molecular Biology Group in Neurex Corp. in Menlo Park. There he headed efforts to discover novel physiological human peptide genes. He also launched a program to create novel therapeutic molecules for the treatment of bladder incontinence. As a post doctoral fellow with Dr. Harold Varmus in the University of California at San Francisco, he constructed a series of gene expression vectors and cell lines that allowed him to investigate the effects of controlling the levels of tumor gene expression in cells. This work provided some of the first insights that tumor genes had far reaching but reversible impacts on cell growth. He then moved to Genentech for a post doctoral term with Dr. Arthur Levinson, where he continued to detail the impact of oncogene expression on various cellular genes. Dr. Jakobovits received his Ph.D. in Genetics from the Weizmann Institute of Science, in Israel where he did research on the structure of the control elements of gene expression in mammalian viral systems.

  15. Bio – Shai Aizin • Mr. Shai Aizin, Counsel for Economic Affairs, to the Government of Israel Economic Mission, Los Angeles Office. Mr. Aizin began his term as the Israeli Consul for Economic Affairs in February, 2005. He came to Los Angeles from the Ministry of Industry, Trade, and Labor. In Jerusalem, he served as the Director of OECD and Import Policy. Prior to this, Mr. Aizin served as the Economic Attaché to Poland from 1998-2002. Mr. Aizin has worked at the Ministry in the Foreign Trade Administration since 1995. He holds a bachelor's degree in both Politics and Public Affairs from the University of Miami and an MBA degree from Heriot-Watt University, Edinburgh.

  16. Bio - Philip Rosenthal • Philip Rosenthal, M.D., is currently Director of Pediatric Hepatology, Medical Director of the Pediatric Liver Transplant Program and a Professor of Pediatrics and Surgery at the University of California, San Francisco (UCSF). He joined the UCSF faculty in 1995, after serving as Professor of Pediatrics at the University of California, Los Angeles (UCLA). Dr. Rosenthal is board certified in Pediatrics and Pediatric Gastroenterology. He received a B.S. degree in Biology from State University of New York at Albany and completed his medical training at Downstate Medical Center and the Albert Einstein Medical Center in New York, after which he completed a fellowship in pediatric gastroenterology at UCSF. Dr. Rosenthal is a prolific author and a recipient of a number of professional honors and awards and is committed to clinical service, research and education. Currently, he is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. 

More Related